Voluntary recall affects specific Amazon Basic Care Extra Strength Pain Relief lots after reports of discolored tablets.
FDA RECALL: More than 112,000 bottles of Amazon-branded acetaminophen have been voluntarily recalled nationwide following consumer complaints about tablet discoloration, according to information released by the U.S. Food and Drug Administration (FDA).
The recall was initiated September 18 by Aurobindo Pharma USA Inc. and affects specific lots of Amazon Basic Care Extra Strength Pain Relief 500 mg acetaminophen caplets sold through Amazon. The action was taken after reports that some tablets appeared discolored.
According to the FDA enforcement report, the recall includes:
•14,640 bottles of 200-count acetaminophen caplets (Lot ACD125040A; expiration Sept. 30, 2027)
•90,456 bottles of 500-count acetaminophen caplets (Lots ACD124036A, ACD124030A, ACD124042A, ACD124048B, and ACD125010A; expiration dates ranging from Sept. 30, 2027, to Feb. 29, 2028)
•7,836 bottles of 1,000-count acetaminophen caplets (Lot ACD124048A; expiration Nov. 30, 2027)
Amazon said the recall was conducted voluntarily in coordination with manufacturer Aurohealth and the FDA. The company has reportedly contacted customers who purchased affected products.
Officials said no adverse health events have been reported in connection with the recalled lots. A health hazard evaluation found that the discoloration does not appear to impact the medication’s safety or effectiveness.
Consumers who purchased Amazon Basic Care Extra Strength Pain Relief acetaminophen should check the lot number and expiration date on their bottle against the recalled products.
Amazon has indicated that eligible customers may receive refunds after confirming disposal of the affected medication.
© 2026 CoastalCarolinaNews.com. All rights reserved.
Be the first to comment